The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002297:Cardanolides; D003327:Coronary Disease / Q000188:drug therapy; D003331:Coronary Vessels / Q000502:physiology; D004071:Digitalis Glycosides; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008026:Ligation; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced / Q000188:drug therapy; D010042:Ouabain; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D012584:Sciatic Nerve / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D002297:Cardanolides; D004071:Digitalis Glycosides; D010042:Ouabain; D011433:Propranolol; D007545:Isoproterenol